Navigation Links
Veridex Completes Acquisition of Immunicon Corporation Assets
Date:8/1/2008

RARITAN, N.J., Aug. 1 /PRNewswire/ -- Veridex, LLC announced today it has completed its previously announced acquisition of substantially all of the assets of Immunicon Corporation (OTC Bulletin Board: IMMC) and its wholly-owned subsidiaries.

The assets acquired include intellectual property, product inventory and clinical data as well as all technologies related to the CellSearch(TM) System, the first diagnostic test to automate the detection and enumeration of circulating tumor cells (CTCs), cancer cells that detach from solid tumors and enter the blood stream. The CellSearch(TM) System is currently cleared for the prognosis and monitoring of patients with metastatic breast, metastatic colorectal and metastatic prostate cancer. As part of the agreement, Veridex also received all technologies related to Repeat-Free(TM) (RF) Poseidon(TM) Fluorescent In-Situ Hybridization (FISH) Probes, which are the latest advance in FISH DNA probes.

"This asset purchase ensures the role of CellSearch(TM) in the future of Veridex," said Ken Berlin, General Manager, Veridex, LLC. "It underscores our continued commitment to the medical community and to cancer patients who may benefit from technologies like the CellSearch(TM) System."

Veridex and Immunicon have partnered since 2000 to develop and commercialize novel cancer diagnostic platforms and products.

About Veridex

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes. For more information, please visit http://www.veridex.com.


'/>"/>
SOURCE Veridex, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
2. Emisstar Completes 2-Year Emission Control Technology Showcase
3. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
4. iCAD Completes Acquisition of CAD Sciences
5. Vertos Medical Inc. Completes Series C Financing
6. Houston-Based Tyrell, Inc. Completes $28 Million Private Equity Financing
7. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
8. Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs
9. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
10. USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
11. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
Breaking Medicine Technology: